(Q48575604)

12 February 2018

title

Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. (English)

1 reference

12 February 2018

author

Johan Gabrielsson

8

1 reference

12 February 2018

author name string

Anna Ollerstam

1

1 reference

12 February 2018

Sandra A G Visser

2

1 reference

12 February 2018

Göran Duker

3

1 reference

12 February 2018

Tomas Forsberg

4

1 reference

12 February 2018

Anna H Persson

5

1 reference

12 February 2018

Lars B Nilsson

6

1 reference

12 February 2018

Jan-Arne Björkman

7

1 reference

12 February 2018

Ahmad Al-Saffar

9

1 reference

12 February 2018

publication date

24 May 2007

1 reference

12 February 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

12 February 2018

volume

56

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

131-144

1 reference

12 February 2018

Drugs, hERG and sudden death

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Clinical trial design to evaluate the effects of drugs on cardiac repolarization: current state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

The QT interval during reflex cardiovascular adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

The assessment of potential for QT interval prolongation with new pharmaceuticals: impact on drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Effect of autonomic nervous function on QT interval in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Optimizing the experimental environment for dog telemetry studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Inhibition of L-type Ca2+ channel current in rat ventricular myocytes by terfenadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Terfenadine block of sodium current in canine atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Effects of three fluoroquinolones on QT interval in healthy adults after single doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

I(Kr) contributes to the altered ventricular repolarization that determines long-term cardiac memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

QT PRODACT: in vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Functional and pharmacological properties of canine ERG potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

Molecular cloning and expression of cERG, the ether à go-go-related gene from canine myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.05.002

10.1016/J.VASCN.2007.05.002

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018